TPS (Transcranial Pulse Stimulation): What It Is, What the Alzheimer’s Research Shows, and Who It May Suit

Transcranial pulse stimulation (TPS) uses short acoustic pulses to stimulate targeted brain regions without surgery. Here is an honest look at how it works and what the evidence for Alzheimer’s and dementia really says.

· 7 min read

In Short

  • TPS (transcranial pulse stimulation) is a non-invasive treatment that sends very short acoustic pulses through the skull to targeted brain regions.
  • It is mainly studied as an add-on for mild to moderate Alzheimer’s; early studies are promising, but the first sham-controlled trial found limited benefit.
  • Many studies used an initial course of about six sessions over two weeks, with sessions of around 30 minutes and mostly mild side effects.
  • TPS has a European CE mark for Alzheimer’s but is not FDA-cleared for this use; it is not a cure and complements existing treatment.

TPS, or transcranial pulse stimulation, is a non-invasive brain stimulation technique that sends very short acoustic (sound-wave) pulses through the skull to reach specific areas of the brain. It has attracted strong interest from families of people living with Alzheimer’s disease and other forms of dementia, because it is one of the few non-drug approaches being studied for memory and thinking problems. This guide explains what TPS is, how it differs from TMS, what the research currently shows, what a course of treatment involves, and how to decide whether it is worth discussing with a specialist.

What is TPS?

Transcranial pulse stimulation is a form of focused, low-energy ultrasound-based neuromodulation. A handheld transducer is placed against the head, with a layer of gel to conduct the pulses, and delivers single pulses lasting only a few microseconds. Because the pulses are so short, they are designed to stimulate brain tissue mechanically without heating it.

The first TPS system received a CE mark in Europe in 2018 for use in Alzheimer’s disease. A CE mark relates to safety and performance standards for sale in Europe; it is not the same as proof that a treatment is clinically effective. TPS is not currently cleared by the US FDA for Alzheimer’s disease, and international Alzheimer’s organisations still describe it as an area that needs more research.

How does TPS work?

Researchers believe the mechanical energy of the pulses may trigger a process called mechanotransduction: nerve cells respond to the physical stimulus with changes in their activity. Laboratory and early clinical studies suggest this could influence blood-vessel growth, the release of growth factors and the connectivity between brain networks involved in memory and language. These mechanisms are still being investigated and have not been fully confirmed in humans.

Treatment is often guided by the patient’s own MRI scan, so that the clinician can track where pulses are delivered and target regions linked to memory, language and attention.

How is TPS different from TMS?

  • Energy type: TPS uses acoustic (mechanical) pulses, while TMS (transcranial magnetic stimulation) uses magnetic fields that induce small electrical currents in the brain.
  • Depth and focus: TPS pulses can be focused to reach somewhat deeper brain areas, whereas standard TMS mainly affects the outer cortex near the coil.
  • Main use: TMS is an established, FDA-cleared treatment for treatment-resistant depression and some other conditions; TPS has mainly been studied in Alzheimer’s disease and is still at an earlier research stage.
  • Sensation: TMS produces a tapping sensation and clicking sounds; TPS is usually felt as a light tapping or nothing at all.

Conditions TPS is being studied for

Most TPS research to date focuses on mild to moderate Alzheimer’s disease. Smaller exploratory studies have also looked at other conditions, but these are very preliminary.

  • Alzheimer’s disease and early memory decline (the main area of research)
  • Mood symptoms that often accompany dementia, such as depression
  • Parkinson’s disease and some other neurological conditions (early, small studies only)

What does the Alzheimer’s evidence show?

The first pilot study, published in 2019, followed 35 patients with Alzheimer’s disease who received TPS over two to four weeks. Their scores on memory and language tests improved, and the changes appeared to last for around three months. However, that study had no placebo (sham) group, so it cannot show how much of the improvement was due to TPS itself.

In 2025, a randomised, sham-controlled crossover trial of 60 patients was published in JAMA Network Open. Overall cognitive gains with real TPS were not clearly greater than with sham treatment, although the authors reported possible benefits in younger patients, improvements in depressive symptoms and changes in brain activity. Several larger controlled trials are now under way. In short, studies suggest TPS may help some people, but the evidence is still early and does not show that it stops or reverses Alzheimer’s disease.

What to expect during a TPS session

  1. Assessment: a specialist reviews the diagnosis, medical history, current medicines and recent brain imaging.
  2. Preparation: you sit comfortably, fully awake. Gel is applied to the scalp; no shaving, needles or anaesthesia are needed.
  3. Stimulation: the clinician moves the handheld device over the planned brain regions. A session usually takes around 30 minutes.
  4. Afterwards: most people return to normal activities straight away and can be accompanied home by a family member.

How many TPS sessions are needed?

There is no single agreed protocol. In published studies, a common starting course has been six sessions over about two weeks, while other protocols have used around ten sessions over several weeks. Some clinics and studies add periodic booster sessions afterwards. Your specialist would explain the plan proposed for your situation and how progress would be measured.

Safety and side effects

In the studies published so far, TPS has generally been well tolerated, and serious side effects have been rare. Reported effects are usually mild and short-lived:

  • Mild headache or a feeling of pressure
  • Temporary discomfort or tingling at the stimulation site
  • Tiredness or changes in mood after a session

TPS is generally not recommended for people with certain metal implants or devices in the head, recent brain bleeding, blood-clotting problems or some other conditions, which is why careful screening comes first.

Is TPS right for me or my family member?

TPS may be worth discussing if a person has a confirmed diagnosis of mild to moderate Alzheimer’s disease or early memory decline, is already under medical care, and the family understands that the treatment is still being studied. It is intended to complement, not replace, existing treatment such as medication, cognitive therapy, physical activity and social support.

If you or someone you care for is living with memory decline and you would like to explore non-surgical options, you are welcome to book a consultation at the brain & nerve unit of Dr. Shaikha AlKubaisi Medical Center in Al Duhail, Doha. The unit offers non-surgical neurostimulation (SOZO), and our team can assess whether this type of treatment is suitable for you, alongside your current care.

Frequently Asked Questions

What is TPS treatment for the brain?

TPS (transcranial pulse stimulation) is a non-invasive treatment that delivers very short acoustic pulses through the skull to targeted brain areas. It is mainly being studied as an add-on treatment for Alzheimer’s disease.

Does TPS work for Alzheimer’s disease?

Early studies suggest it may help some patients with memory, language or mood, but the evidence is still limited. The first sham-controlled trial found limited overall cognitive benefit, and larger trials are ongoing. It is not a cure.

How many TPS sessions are usually given?

Many studies have used an initial course of about six sessions over two weeks, while others used around ten sessions. Some protocols add booster sessions later. The plan depends on the individual assessment.

Is TPS painful or dangerous?

Most people feel little or nothing during a session. Reported side effects are usually mild, such as headache or temporary discomfort. Screening is important because TPS is not suitable for everyone, for example people with certain implants.

What is the difference between TPS and TMS?

TPS uses acoustic pulses that can reach somewhat deeper brain regions, while TMS uses magnetic fields that mainly act on the brain surface. TMS is an established treatment for depression; TPS is at an earlier stage of research.

Is TPS FDA approved?

TPS has a CE mark in Europe for Alzheimer’s disease, but it is not currently cleared by the US FDA for this use. A CE mark is not proof of clinical effectiveness.

Have questions about your case?

Book a consultation with our specialists in Al Duhail, Doha to find the treatment that suits you.

This article is for general information and does not replace a medical consultation. Suitability and results vary from person to person.